Oxler Private Wealth’s Idexx Laboratories IDXX Stock Holding History

Oxler Private Wealth’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$869K	Sell	1,650 -73	-4%	-$40.9K	0.25%	47
2026 Q1	$968K	Hold	1,723	–	–	0.3%	42
2025 Q4	$1.17M	Buy	1,723 +41	+2%	+$27.9K	0.34%	38
2025 Q3	$1.07M	Hold	1,682	–	–	0.31%	39
2025 Q2	$902K	Hold	1,682	–	–	0.28%	45
2025 Q1	$706K	Sell	1,682 -13	-0.8%	-$5.64K	0.25%	49
2024 Q4	$701K	Hold	1,695	–	–	0.23%	55
2024 Q3	$856K	Hold	1,695	–	–	0.3%	46
2024 Q2	$826K	Sell	1,695 -30	-2%	-$15.1K	0.31%	47
2024 Q1	$931K	Buy	1,725 +1,270	+279%	+$694K	0.37%	46
2023 Q4	$253K	Sell	455 -1,270	-74%	-$596K	0.21%	65
2023 Q3	$754K	Hold	1,725	–	–	0.38%	53
2023 Q2	$866K	Hold	1,725	–	–	0.41%	52
2023 Q1	$863K	Hold	1,725	–	–	0.43%	51
2022 Q4	$704K	Hold	1,725	–	–	0.38%	59
2022 Q3	$562K	Hold	1,725	–	–	0.31%	67
2022 Q2	$605K	Buy	1,725 +1,270	+279%	+$518K	0.29%	72
2022 Q1	$248K	Hold	455	–	–	0.11%	101
2021 Q4	$299K	Sell	455 -7	-2%	-$4.39K	0.12%	106
2021 Q3	$287K	Hold	462	–	–	0.13%	111
2021 Q2	$291K	Hold	462	–	–	0.13%	114
2021 Q1	$226K	Hold	462	–	–	0.11%	112
2020 Q4	$230K	Buy	+462	New	+$207K	0.13%	97

Other funds holding IDXX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Oxler Private Wealth's IDXX Position: Q2 2026 in Review

Oxler Private Wealth reduced its Idexx Laboratories (IDXX) stake by 4.2% in Q2 2026, selling an estimated $40.9K and leaving 1,650 shares worth $869K. The position accounts for 0.25% of the portfolio, ranked #47.

Oxler Private Wealth first reported a position in IDXX in Q4 2020 and has held it in 23 quarters since. The position peaked at $1.17M in Q4 2025. 1,305 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

Oxler Private Wealth held 1,650 shares of Idexx Laboratories worth $869K as of Q2 2026.
Oxler Private Wealth sold 73 Idexx Laboratories shares in Q2 2026, an estimated $40.9K.
Idexx Laboratories made up 0.25% of Oxler Private Wealth's portfolio in Q2 2026, its #47 holding.
Oxler Private Wealth first reported a position in Idexx Laboratories in Q4 2020 and has held it in 23 quarters since.
Oxler Private Wealth's Idexx Laboratories position peaked at $1.17M in Q4 2025.
1,305 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Oxler Private Wealth's 13F filing for Q2 2026, filed 3 Aug 2026.